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ABSTRACT 
Objective: Three sensitive, simple, precise, reproducible, and validated spectrophotometric methods have been developed for the determination of 
anti-psychotic drug (asenapine maleate) in pure and pharmaceutical dosage forms.  
Methods: The methods are based on the formation of yellow-colored ion-pair complex between asenapine maleate and three acid dyes, namely, 
bromocresol purple (BCP), bromophenol blue (BPB) and bromothymol blue (BTB) with absorption maxima at 410, 414 and 416 nm, respectively. 
Several parameters such as pH, buffer type and volume, reagent volume, the sequence of addition and effect of extracting solvent were optimized. 
Results: Under the optimum experimental conditions, beer’s law is obeyed over the concentration ranges of 1.0–20, 1.0–14, and 1.0-16 μg/ml for 
BCP, BPB and BTB, respectively, with good correlation coefficients (0.9994-0.9998). The apparent molar absorptivity and Sandell’s sensitivity 
values are reported for all methods. The limit of detection (LOD) and the limit of quantification (LOQ) values are found to be 0.27, 0.30, and 0.25 
μg/ml and 0.90, 1.0, and 0.83 μg/ml for BCP, BPB and BTB, respectively. The stoichiometric ratio of the formed ion-pair complexes was found to be 
1:1 (drug: reagent) for all methods, as deduced by Job's method of continuous variation. 
Conclusion: The proposed methods were successfully applied for the determination of asenapine maleate in pharmaceutical formulations with 
good accuracy and precision. Statistical comparison of the results was performed using Student's t-test and variance ratio F-test at the 95% 
confidence level and there was no significant difference between the reported and proposed methods regarding accuracy and precision. Further, the 
validity of the proposed methods was confirmed by recovery studies via standard addition technique in accordance with ICH guidelines. 
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INTRODUCTION 
Asenapine Maleate (ASP) is chemically designated as (3aRS,12bRS)-
rel-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz (2,3:6,7) 
oxepino4,5-c] pyrrole maleate (fig. 1) [1]. ASP is an atypical 
antipsychotic drug and it was approved for use in the USA in for the 
treatment of schizophrenia and bipolar disorder. It shows a high 
affinity for numerous receptors like serotonin, adrenergic, 
dopamine, histamine [2]. 
 
 
Fig. 1: The chemical structure of asenapine maleate (ASP) 
 
The literature survey revealed that many methods were 
described for the determination of ASP in pure, tablet dosage 
forms and biological fluids such as spectrofluorimetry [3], high-
performance liquid chromatography (HPLC) [4-15], stability 
indicating HPLC methods [16-21], thin layer chromatography 
[22], gas chromatography [23], potentiometry [24] and 
titrimetric method [25]. Most of these reported methods are 
either not appropriately sensitive or tedious and utilized 
expensive instruments that are not available in most quality 
control laboratories. 
Visible spectrophotometry is considered as the most convenient 
analytical technique in most quality control and clinical laboratories, 
hospitals and pharmaceutical industries for the assay of different 
classes of drugs in pure form, pharmaceutical formulations and 
biological samples, due to its simplicity, less expensive, less time 
consuming and reasonable sensitivity with significant economic 
advantages.  
To the best of our knowledge, there are few methods that have been 
reported for the quantification of ASP in commercial dosage forms 
using a spectrophotometric technique [26-31] (table 1). However, 
these previously reported methods suffer from one or more 
disadvantage such as poor sensitivity, depending on critical 
experimental variables, few methods require a rigid pH control and 
tedious and time-consuming liquid-liquid extraction step; some 
other methods have a relatively narrow dynamic linear range, 
involve a heating step, and/or use of expensive reagent or large 
amounts of organic solvents. For these reasons, it was worthwhile to 
develop a new, simple, cost-effective and selective 
spectrophotometric method for the determination of ASP their 
pharmaceutical dosage forms. 
The aim of the present work is to develop simple, sensitive, 
accurate, precise, low-cost and validated extractive 
spectrophotometric methods for the determination of ASP in pure 
and dosage forms. The proposed methods are based on the ability 
of ASP to form stable ion-pair complexes with bromocresol purple 
(BCP), bromophenol blue (BPB) and bromothymol blue (BTB). No 
interference was observed in the assay of ASP from common 
excipients in levels found in dosage forms. These methods are 
validated by statistical data. 
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Table 1: Comparison between the reported spectrophotometric methods and the present method for the determination of ASP 







UV-spectroscopy 215 5.0-20 NA 0.929 [26] 
230 5.0-20 NA 0.471 
Absorption ration at 
215 and 230 
5.0-20 NA 1.75 
UV-spectroscopy 








  0.0122 
 
[27] 
b- Area under curve 263-274 10-60 6.39 x 103 0.0122   
UV-spectrophotometry 270 10-60 NA 1.4 [28] 
 
UV-spectrophotometry 220 2.0-10 1.1 x 10 0.20381 4 [29] 
UV-spectrophotometry 270 1.0-90 NA NA [13] 
Bromocresol green 415 5.0-30 NA 0.39 [30] 
Folin ciocalteu (FC)  769 4.0-20 7.5 x 10 0.271 4 [31] 
Bromocresol purple (BCP) 410 1.0-16 2.136 x 10 0.27 4 Proposed  
work Bromophenol blue (BPB) 414 1.0-14 2.607 x 10 0.30 4 
Bromothymol blue (BTB) 416 1.0-20 1.539 x 10 0.25 4 
NA: not available. 
 
MATERIALS AND METHODS 
Instruments 
All absorption spectra were made using Varian UV–Vis 
spectrophotometer (Cary 100 Conc., Australia) equipped with 10 
mm quartz cell was used for absorbance measurements. This 
spectrophotometer has a wavelength accuracy of±0.2 nm with a 
scanning speed of 200 nm/min and a bandwidth of 2.0 nm in the 
wavelength range of 200–900 nm. The pH values of different buffer 
solutions were checked using a Hanna pH-meter instrument (pH 
211) (Romania) equipped with a combined glass-calomel electrode. 
Materials and reagents 
All reagents, chemicals and solvents used were of analytical or 
pharmaceutical grade and all solutions were prepared fresh daily. 
Bidistilled water was used throughout the investigation. 
Pure sample of ASP was kindly supplied by Hikma Pharma SAE, 6th 
October, Egypt, with a purity of 99.60±1.20% by applying the reported 
method [30]. Asenadia tablets, labeled to contain 10 mg ASP per 
sublingual tablet, a product of Western Pharmaceutical Industries 
Company, Cairo, Egypt. Asenapine-Hikma Pharma tablets, labeled to 
contain 5.0 mg ASP per sublingual tablet, a product of Hikma Pharma 
SAE, 6th
Preparation of stock standard solution 
 October, Egypt were purchased from local pharmacies. 
Stock standard solutions (100 μg/ml) and (1.0 × 10−3
Reagents 
 mol/l) of ASP 
were prepared by dissolving 10 and 40.18 mg of pure ASP in the 
least amount of methanol and further diluted with bidistilled water 
to the mark in a 100 ml volumetric flask. The standard solutions 
were stable for at least 7.0 d when kept in the refrigerator. Serial 
dilution with the same solvent was performed to obtain the 
appropriate concentration range. 
BCP, BPB and BTB (BDH Chemicals LTD, Poole, England) and used 
without further purification. Stock solutions (0.1%, w/v) or 
(1.0×10−3
Series of buffer solutions of NaOAc–HCl (pH=1.99-4.92), NaOAc–
AcOH (pH=3.4-5.6) and potassium hydrogen phthalate–HCl (pH=2.0-
7.0) were prepared by following the standard methods [32]. The pH 
of each solution was adjusted to an appropriate value by the 
addition of 0.2 mol/l hydrochloric acid or sodium hydroxide with the 
help of the pH meter. Freshly prepared solutions were always 
employed. Chloroform, methylene chloride, and carbon tetrachloride 
were obtained from (BDH Chemicals Ltd., Poole, England) and 
anhydrous sodium sulfate was obtained from (Prolabo). 
 mol/l) of reagents were prepared by dissolving the 
appropriate weight of each reagent in10 ml of 96% ethanol and 
diluted to 100 ml with bidistilled water. These solutions were kept 
in the refrigerator. 
General recommended procedure  
Accurately measured aliquots (0.1–2.0 ml) of standard ASP solution 
(100 µg/ml) was transferred into 10 ml measuring flasks. 3.0 ml 
NaOAc–AcOH buffer at the optimum pH 4.0, 3.5 and 4.0 using BCP, 
BPB and BTB, respectively, were added. Then, 2.0 ml of the BCP, BPB 
and BTB (0.1%, w/v) was added and the volume was completed to 
10 ml with bidistilled water. The formed ion associate complexes 
were extracted with 10 ml methylene chloride. The solution was 
shaking for 2.0 min, then allowed to stand for clear separation of the 
two phases and the methylene chloride layer was passed through 
anhydrous sodium sulfate. The absorbance of the yellow-colored 
ion-pair complexes was measured at 410, 414 and 416 nm using 
BCP, BPB and BTB, respectively, against the corresponding reagent 
blank similarly prepared. All measurements were made at room 
temperature (25±2 °C). In the three proposed methods, a standard 
curve was prepared by plotting the absorbance values versus 
concentrations of ASP to calculate the amount of drug in unknown 
analyte samples.  
Applications for dosage forms (tablets) 
Twenty tablets containing ASP were finely pulverized and 
weighed. A weighed quantity of the powdered tablets equivalent 
to 10 mg of ASP was transferred into a 100 ml volumetric flask, 
about 20 ml of methanol was added and the flask was sonicated 
for 30 min. The volume was completed to the mark with 
bidistilled water, mixed well and filtered through a Whatman 
No.1 filter paper into 100 ml volumetric flask, discarding the 
first 10 ml; then, the conical flask was washed with bidistilled 
water. The wash was added to the same volumetric flask, and 
then the flask was made up to volume with bidistilled water. 
Aliquots containing ASP in the final concentration ranges were 
analyzed as described under “General recommended procedure”. 
The concentration of ASP was determined either from the 
calibration curve or using the corresponding regression 
equation. The method of standard addition was used for the 
accurate determination of ASP content. 
Stoichiometric relationship  
The stoichiometric ratios of the ion-associates formed between 
ASP and the reagents were determined by applying the continuous 
variation [33] and the molar ratio [34] methods at the optimum 
wavelengths. In the continuous variation method, equimolar 
solutions were employed: a 1.0 x 10-4 mol/l standard solution of 
ASP and 1.0 x 10-4 mol/l solution of dye were used. A series of 
solutions was prepared in which the total volume of ASP and the 
dye was kept at 2.0 ml. The drug and reagent were mixed in 
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various complementary proportions (0.2:1.8, 0.4:1.6, 0.6:1.4, 
0.8:1.2, 1.0:1.0, 1.2:0.8, 1.4:0.6, 1.6:0.4, 1.8:0.2) and completed to 
volume in a 10 ml calibrated flask with the appropriate solvent for 
extraction following the above mentioned procedure. In the molar 
ratio method, the concentration of ASP is kept constant to 1.0 ml of 
(1.0 x10-4 mol/l) while that of dye (1.0 x10-4
RESULTS AND DISCUSSION  
 mol/l) is regularly 
varied (0.2–2.4 ml). The absorbance of the prepared solutions was 
measured at optimum condition and at the optimum wavelength 
for each complex. 
Absorption spectra 
The nitrogenous drugs are present in positively charged 
protonated forms and anionic dyes present mainly in anionic 
form at pH ≥ 2.5. So, when treated with an acid dye at acidic pH 
using buffer solutions, a yellow ion-pair complex which is 
extracted with methylene chloride is formed. The absorption 
spectra of the ion-pair complexes, which were formed between 
ASP and reagents, were measured in the range 350–550 nm 
against the blank solution and the maximum absorbances were 
measured at wavelengths 410, 414, and 416 nm using BCP, BPB, 
and BTB, respectively.  
Optimum reaction conditions for complex formation 
The optimization of the methods was carefully studied to achieve the 
complete reaction formation, highest sensitivity and maximum 
absorbance. Reaction conditions of the ion-pair complex were found 
by studying with preliminary experiments such as pH of the buffer, 
the type of organic solvent, volumes of the dye, reaction time and 
temperature for the extraction of ion-pair complexes.  
Effects of pH  
It was observed that the effective extraction of the complex depends 
on the type of the buffer used and its pH value. The effect of pH was 
studied by extracting the colored complexes in the presence of 
various buffers such as NaOAc–HCl (pH=2.0-4.5), NaOAc–AcOH 
(pH=2.8-5.5) and potassium hydrogen phthalate–HCl (pH=3.0-6.0). 
It is evident that the maximum color intensity and maximum 
absorbance were found in NaOAc-AcOH buffer. It is evident that the 
maximum absorbances of the ion pair complexes were obtained at 
pH 4.0, 3.5, and 4.0 for BCP, BPB and BTB methods, respectively (fig. 
2). Buffer volume was determined by applying the same experiment 
and variation the volume regularly (0.5-5.0 ml). The higher 
absorbance value and reproducible results were obtained by using 
3.0 ml of acetate buffer solutions. 
  
 
Fig. 2: Effect of pH of buffer solution on the ion pair complex formation between (20, 14 and 16 μg/ml) ASP and (0.1%, w/v) BCP, BPB and 
BTB reagents, respectively, (N=3.0) 
 
Effect of reagent concentration 
The effect of the reagent was studied by measuring the 
absorbances of solutions containing a fixed concentration of ASP 
and various volumes of the BCP, BPB or BTB (0.1%, w/v) reagents 
in the range of (0.5–4.0 ml). The results showed that the 
absorbance of the extracted ion-pair increased by increasing the 
BCP, BPB or BTB volume till 2.0 ml. So, the maximum color 
intensity of the complex was achieved with 2.0 ml of (0.1 %, w/v) 
of each reagent solution. Although a larger volume of the reagent 
had no pronounced effect on the absorbance of the formed ion-
pair complexes (fig. 3). 
 
 
Fig. 3: Effect of volume of (0.1%, w/v) BCP, BPB and BTB reagent on the ion pair complex formation with (20, 14 and 16 μg/ml) ASP, 
respectively, (N=3.0) 
 
Choice of extracting solvent  
The effect of several organic solvents viz., chloroform, carbon 
tetrachloride, dichloromethane and diethyl ether were studied for 
effective extraction of the colored species from the aqueous phase 
(fig. 4). Dichloromethane was found to be the most suitable solvent 
for the extraction of colored ion-pair complexes for all reagents 
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quantitatively. Experimental results indicated that double extraction 
with total volume 10 ml dichloromethane, yielding maximum 
absorbance intensity, stable absorbance and considerably lower 
extraction ability for the reagent blank and the shortest time to 
reach the equilibrium between both phases. 
 
 
Fig. 4: Effect of extraction solvent on the ion pair complex formation of ASP with dyes at the optimum conditions 
 
Effect of shaking time and temperature 
The optimum shaking time was investigated by shaking from 0.5-
5.0 min at ambient temperature (25±2 °C). Maximum and constant 
absorbance values were obtained when extracted after 2.0 min of 
shaking for all complexes. Therefore, a shaking time of 2.0 min was 
maintained throughout the experiment. The effect of temperature on 
colored complexes was studied by measuring the absorbance values 
over the temperature range 20-35 °C. It was found that the 
absorbance of the colored ion-pair complex was constantly up to 30 
°C. At higher temperatures, the drug concentration was found to 
increase due to the volatile nature of dichloromethane. Therefore, 
the temperature chosen was room temperature (25±2 °C) as the 
best temperature for the determination of ASP in bulk and 
pharmaceutical formulations. The absorbance of the complexes 
remains stable for at least 12 h at room temperature.  
Composition of the ion-pair complexes 
The molar ratio of the ion pair complexes (ASP: dye) was 
determined by the continuous variations and molar ratio methods 
(figs. 5 and 6). The results indicate that the molar ratio of (ASP: dye) 
is (1:1) ion-pair complex are formed through the electrostatic 
attraction between the positively charged ASP+and negatively 
charged dye, (BCP−, BPB−, and BTB−
D(aq) (aq) (org)ASP(aq) ASP ASP D  D
). The extraction equilibrium can 
be represented as follows:  
 
Where ASP+andD− represent the protonated drug and the anion of 
the dye (BCP−, BPB− or BTB−
 
), respectively, and the subscript (aq) 
and (org) refer to the aqueous and organic phases, respectively 
(scheme 1). 
pH= 4.0




































Scheme 1: Proposed reaction mechanism for the ion pair complex formation between ASP and BCP 
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Fig. 5: Job’s method of continuous variation graph for the reaction of ASP with BCP, BPB and BTB, [drug] = [dye] = (1.0×10−4
 
 mol/l) (N=3.0) 
 
Fig. 6: Mole ratio plots for the ion-association complexes of ASP (1.0 x 10-4 mol/l) with various volumes of reagent solution (1.0 x 10-4
 
 
mol/l) at the optimum conditions 
Method of validation 
Linearity 
At described experimental conditions for ASP determination, standard 
calibration curves with reagents were constructed by plotting 
absorbance vs. concentration of ASP. The statistical parameters were 
given in the regression equations calculated from the calibration 
graphs A = aC+b, where A is the absorbance and C is the concentration 
in μg/ml. The linearity of calibration graphs was proved by the high 
values of the correlation coefficient (r) and the small values of the y-
intercepts of the regression equations. The apparent molar 
absorptivity of the resulting colored ion-pair complexes and relative 
standard deviation of response factors for each proposed 
spectrophotometric method was also calculated and recorded in table 
2. The molar absorptivity of BPB>BCP>BTB ion-pair complexes. 
Sensitivity 
The limits of detection (LOD) and quantitation (LOQ) for the proposed 
methods were calculated using the following equation [35, 36]:  
LOD = 3s/k and 
LOQ = 10 s/k 
Wheres is the standard deviation of ten replicate determinations 
values of the reagent blank and k is the sensitivity, namely the slope 
of the calibration graph. In accordance with the formula, LOD was 
found to be 0.27, 0.30, and 0.25 μg/ml for BCP, BPB and BTB 
methods, respectively.  
According to this equation, LOQ was found to be 0.90, 1.0, and 0.83 
μg/ml for BCP, BPB and BTB methods, respectively. 
 
Table 2: Statistical analysis of calibration graphs and analytical data in the determination of ASP using the proposed methods 
Parameters BCP BPB BTB 
Wavelengths λ  max 410  (nm) 414 416 
Beer’s law limits (µg/ml) 1.0-20 1.0-14 1.0-16 
Molar absorptivity ε, (L/mol. cm) x 10 2.136 4 2.607 1.539 
Sandell,s sensitivity (ng/cm2 18.81 ) 15.41 26.10 
Regression equation  a   
Intercept (a) 0.0085 0.0054 0.0052 
Standard deviation of intercept (Sa) 0.012 0.007 0.009 
Slope (b) 0.0499 0.0628 0.0365 
Standard deviation of slope (Sb) 0.005 0.005 0.004 
Correlation coefficient (r2 0.9998 ) 0.9994 0.9996 
LOD (µg/ml) 0.27 b 0.30 0.25 
LOQ (µg/ml) 0.90 b 1.0 0.83 
mean±SD 99.79±0.80 100.25±0.85 99.85±0.93 
RSD% (N=6) 0.80 0.85 0.93 
RE% 0.84 0.89 0.98 
t-test c 0.29   0.99 0.37 
F-test 2.25 c 1.99 1.66 
aA = a+bC, where C is the concentration in µg ml−1, A is the absorbance units, bLOD, limit of detection; LOQ, the limit of quantification; ε, molar 
absorptivity, theoretical values of t and F at P= 0.05 are 2.571 and 5.05, respectively. 
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Accuracy and precision  
In order to evaluate the accuracy and precision of the proposed 
methods, solutions containing three different concentrations of ASP 
were prepared and the assay procedure was analyzed in six 
replicates, and percentage relative standard deviation (RSD%) 
values were obtained within the same day to evaluate the 
repeatability (intra-day precision) and over five different days to 
evaluate intermediate precision (inter-day precision). The 
percentage relative error (RE%) was calculated using the following 
equation:  
 
The analytical results of intra-day and inter-day precision (RSD%) 
and accuracy (RE%) were summarized in table 3. These results of 
accuracy and precision show that the proposed methods have good 
repeatability and reproducibility. 
 
Table 3: Intra-day and Inter-day precision and accuracy data for ASP obtained by the proposed methods 
















a RE % 
Confidence 
limit b 
BCG 6.0 99.00 0.48 -1.0 5.94±0.03 98.90 0.53 -1.10 5.934±0.033 
12 99.20 0.70 -0.80 11.904±0.087 99.80 0.81 -0.20 11.976±0.102 
18 100.40 1.30 0.40 18.072±0.247 99.20 0.95 -0.80 17.856±0.178 
BPB 4.0 99.20 0.67 -0.80 3.968±0.028 99.10 0.50 -0.90 3.964±0.021 
8.0 99.00 1.10 -1.0 7.92±0.091 99.30 0.47 -0.70 7.944±0.039 
12 99.60 1.50 -0.40 11.952±0.188 99.50 0.80 0.50 11.94±0.1 
BTB 5.0 99.10 0.80 -0.90 4.955±0.042 98.70 0.40 -1.30 4.935±0.021 
10 100.50 0.90 0.50 10.05±0.095 99.30 0.66 -0.70 9.93±0.069 
15 99.70 0.75 -0.30 14.955±0.118 100.80 1.20 0.80 15.12±0.19 
aMean of six determination, RSD%, percentage relative standard deviation; RE%, percentage relative error, b
 
Confidence limit at 95% confidence 
level and five degrees of freedom (t = 2.571). 
Robustness and ruggedness 
For the evaluation of the method robustness, some parameters were 
interchanged; pH, dye concentration, wavelength range, and shaking 
time. The capacity remains unaffected by small deliberate variations. 
Method ruggedness was expressed as RSD% of the same procedure 
applied by two analysts and in two different instruments on 
different days. The results showed no statistical differences between 
different analysts and instruments, suggesting that the developed 
methods were robust and rugged (table 4). 
 
Table 4: Results of method robustness and ruggedness expressed as intermediate precision (RSD %) for ASP-dye ion-pair complex 





pH Dye concentrationb Inter-analysts  c Inter-instruments 
BCP 6.0 0.80 0.75 1.20 1.10 
 12 1.20 1.0 1.90 1.70 
 18 2.0 1.70 2.30 2.40 
BPB 4.0 0.65 0.90 0.85 0.70 
 8.0 0.90 1.50 1.30 1.60 
 12 1.80 2.10 1.90 2.0 
BTB 5.0 0.95 1.20 1.0 0.80 
 10 1.70 1.80 1.10 1.80 
 15 2.20 2.30 1.75 2.40 
aMean of three determinations, bpH (±0.2), c
 
The volumes of dye used were 2.0±0.2 ml. 
Table 5: Application of the standard addition method for the determination of ASP in dosage forms (tablets) using the proposed methods 
Method Taken drug 
(μg/ml) 
 
Pure drug  
added  
(μg/ml) 













BCP 5.0 5.0 9.93 99.30±0.60 9.88 98.80±0.40 
5.0 10 15.075 100.50±0.75 14.93 99.53±0.64 
5.0 15 19.84 99.20±1.10 20.14 100.70±1.50 
BPB 4.0 4.0 7.92 99.00±0.36 7.95 99.70±0.55 
4.0 6.0 9.98 99.80±0.80 9.95 99.50±0.68 
4.0 8.0 12.05 100.42±1.40 11.88 99.00±1.60 
BTB 4.0 4.0 7.93 99.13±0.70 7.94 99.25±0.65 
4.0 6.0 9.94 99.40±1.30 10.09 100.90±0.80 
4.0 8.0 11.86 98.83±1.90 11.97 99.75±1.20 
a
 
Average of six determinations. 
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Effects of interference 
To assess the usefulness of the method, the effect of diluents, 
excipients and additives which often accompany ASP in its dosage 
forms (starch, lactose, glucose, saccharose, talc, sodium chloride, 
titanium dioxide, and magnesium stearate) was studied. The results 
indicated that there is no interference from excipients and additives, 
indicating a high selectivity for determining ASP in its dosage forms. 
Applications to dosage forms  
The proposed methods have been successfully applied to the 
determination of ASP in dosage forms (Asenapine-Hikma Pharma 
tablets and Asenadia tablets). Six replicates determinations were 
made. Moreover, to check the validity of the proposed methods, 
dosage forms were tested for possible interference with standard 
addition method (table 5). Therefore, it is concluded that the 
excipients in dosage forms of ASP did not cause any interference in 
the analysis of ASP. A statistical comparison of the results for the 
determination of ASP in tablet dosage forms using the proposed and 
reported methods [30] is shown in table 6. Statistical analysis of the 
results using Student’s t-test for accuracy and F-test for precision 
revealed no significant difference between the proposed and 
reported methods at the 95 % confidence level with respect to 
accuracy and precision [36] (table 6). 
 
Table 6: Results of analysis of tablets by the proposed methods for the determination of ASP and statistical comparison with the reported 
method [30] 
Samples Recoverya (%)±SD 
Proposed methods Reported  
method [30] BCP BPB BTB 
Asenapine-Hikma Pharma tablets (5.0 mg) 99.67±0.72 99.74±0.71 99.12±0.29 99.40±0.54 
t-value 0.67 b 0.85 1.02  
F-value 1.78 b 1.73 3.47  
Asenadia tablets (10 mg) 99.68±0.96 99.40±0.36 99.97±0.85 99.78±0.60 
t-value 0.20 b 1.21 0.41  
F-value 2.56 b 2.78 2.01  
aAverage of six determinations, b
 
The theoretical values of t and F are 2.571 and 5.05, respectively at confidence limit at 95% confidence level and 
five degrees of freedom (p = 0.05). 
CONCLUSION 
The proposed methods describe the application of extractive ion–
pair complex formation reaction with dyes for the quantification of 
ASP in pure and dosage forms. Compared with the existing 
spectrophotometric methods, the proposed methods have the 
advantages of relatively simple, rapid, cost-effective, and more 
sensitive for determining ASP in pure and dosage forms. Moreover, 
the proposed methods are free from tedious experimental steps 
such as heating unlike the previously reported spectrophotometric 
methods cited earlier. The most attractive feature of these methods 
is its relative freedom from interference by the usual diluents and 
excipients in amounts far in excess of their normal occurrence in 
pharmaceutical formulations. The statistical parameters and the 
recovery data reveal high precision and accuracy of the proposed 
methods besides being robust and rugged. Therefore, the validated 
method could be useful for routine quality control assay of ASP in 
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